- Home
- CELC vs SDRL Comparison
CELC vs SDRL Comparison
Compare CELC & SDRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CELC | SDRL |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.7B |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CELC | SDRL |
|---|---|---|
| Price | $114.28 | $42.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $106.63 | $51.75 |
| AVG Volume (30 Days) | 527.9K | ★ 828.6K |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.61 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,437,000,000.00 |
| Revenue This Year | N/A | $3.48 |
| Revenue Next Year | N/A | $14.44 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 3.75 |
| 52 Week Low | $7.58 | $18.60 |
| 52 Week High | $120.32 | $45.90 |
Technical Indicators
Market Signals| Indicator | CELC | SDRL |
|---|---|---|
| Relative Strength Index (RSI) | 56.01 | 53.26 |
| Support Level | $97.75 | $41.73 |
| Resistance Level | $114.54 | $45.32 |
| Average True Range (ATR) | 5.14 | 1.68 |
| MACD | 0.36 | -0.41 |
| Stochastic Oscillator | 63.53 | 29.63 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About SDRL Seadrill Limited
Seadrill Ltd is an offshore drilling contractor company. The company is engaged in providing offshore drilling services to the oil and gas industry. The primary business of the company is the ownership and operation of drillships, semi-submersible rigs, and jack-up rigs for operations in shallow to ultra-deepwater areas in both benign and harsh environments. The geographical segments of the company are the United States, Brazil, Angola, Norway, Canada and others. The company derives maximum revenue from the United States.